Skip to main content
. 2021 Aug 26;21(17):5751. doi: 10.3390/s21175751

Table 1.

Comparison between the clinical and demographic features of experimental and control groups at T1.

Feature Experimental Group (n = 24) Control Group (n = 18) p=
M-NCD etiology, n
Vascular 11 4 0.41 a
Alzheimer 8 7
Fronto-temporal 2 3
Other 3 4
M-NCD severity level, n
MMSE < 18 6 6 0.54 a
MMSE 18–23 16 10
MMSE > 23 2 2
Gender, M/F, n 13/11 6/12 0.18 a
Chronological age, years * 68.5 (61.8/72.1) 64.0 (61.3/69.8) 0.28 b
Education, years * 8.0 (5.0/11.0) 8.0 (5.0/13.0) 0.47 b
Mini Mental State Examination c * 20.1 (18.0/21.9) 19.6 (15.6/20.5) 0.19 b
Coloured Progressive Matricesc * 20.1 (18.1/24.3) 19.0 (14.4/24.3) 0.47b
Visuo-spatial span (Corsi’s test)c * 4.3 (3.4/4.7) 3.6 (2.6/4.1) 0.19 b
Digit Spanc * 4.5 (3.5/4.9) 4.1 (3.9/4.7) 0.35 b
Rey’s 15 words, Immediate Recallc * 26.0 (22.3/28.7) 21.3 (17.2/25.5) 0.1 b
Rey’s 15 words, Delayed Recallc * 3.5 (2.5/5.4) 2.0 (0.0/4.2) 0.55 b
Frontal Assessment Battery * 9.5 (8.0/11.0) 8.5 (6.0/11.0) 0.75 b
ADL * 6.0 (4.0/6.0) 6.0 (5.0/6.0) 0.62 b
IADL, % * 37.5 (25.0/62.5) 62.3 (50.0/62.5) 0.3 b
Information, correct responses * 24.0 (21.0/26.3) 24.0. (22.0/26.0) 0.99 b
Information, total time, s * 264.5 (233.8/286.5) 314 (245.5/367.3) 0.04
Suitcase, correct responses * 5.0 (3.0/7.3) 5.0 (3.0/9.0) 0.5 b
Suitcase, total time, s * 200.0 (128.0/263.8) 214.0 (173.0/395.0) 0.38 b
Medicines, correct responses * 6.5 (4.3/8.0) 5 (3.5/6.5) 0.31 b
Medicines, total time, s * 179.5 (156.3/230.5) 261.5 (218.8/377.3) 0.01
Supermarket, correct responses * 10.0 (7.0/13.0) 9.0 (5.0/12.0) 0.56 b
Supermarket, total time, s * 270.0 (227.8/393.0) 343.0 (284.5/370.5) 0.52 b

* Data reported as median (25–75th centile). M-NCD = major neurocognitive disorder; a Chi square test; b Mann Whitney’s U test; c corrected scores (age/education).